Newborn babies are subjected to a heel prick test, which is used to screen for various genetic conditions. The test is being expanded in some areas to include screening for additional conditions, such as spinal muscular atrophy, although its implementation and use of collected data have raised concerns about privacy and public health. The test's effectiveness and scope vary by region, with some areas reporting possible gaps in screening and others utilizing the collected data for research or law enforcement purposes.